Cardiovascular magnetic resonance imaging in childhood clinical indications and case studies;Kardiovaskuläre magnetresonanztomografie im kindesalter klinische indikationen und beispiele

Klinische Padiatrie

Volumn 222, Issue 1, 2010, Pages 3-12

  Voges, I ^a   Jerosch Herold, M ^b   Plagemann, T ^a   Hart, C ^a   Hansen, T ^a   Helle, M ^a   Kramer, H H ^a   Rickers, C ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acquired heart disease; Cardiac imaging; Cardiovascular magnetic resonance imaging; Congenital heart disease; Pediatric cardiology

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE IMAGING; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC REASONING; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS; REVIEW;

ADOLESCENT; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; HEART DEFECTS, CONGENITAL; HEART NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; INFANT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MARFAN SYNDROME; MUCOCUTANEOUS LYMPH NODE SYNDROME; SENSITIVITY AND SPECIFICITY;

EID: 76649129011     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1239526     Document Type: Review

References (44)

1. Abolmaali ND, etal. Reference values of MRI flow measurements of the pulmonary outflow tract in healthy children. Rofo 2004 176 837-845
2. Amis ES Jr, etal. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 2007 4 272-284
3. Alfakih K, etal. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol 2004 14 1813-1822
4. Arnold R, etal. Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparison to conventional coronary catheterization. Pediatr Radiol 2007 37 998-1006
5. Assomull RG, etal. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006 48 1977-1985
6. Baudendistel KT, Heverhagen JT, Knopp MV. Klinische MRT bei 3 Tesla: Aktueller Stand. Der Radiologe 2004 44 11-18
7. Beerbaum P, etal. Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation 2001 103 2476-2482
8. Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005 26 433-439
9. Bruder O, Erbel R, Kreitner KF. Kardiomyopathien und Myokarditis. In: Thelen M, Erbel R, Kreitner KF, Barkhausen J, Hrsg. Bildgebende Kardiodiagnostik mit MRT, CT, Echokardiografie und anderen Verfahren Thieme, Stuttgart 2007 S231-233
10. Cantinotti M, etal. Diagnostic role of magnetic resonance imaging in identifying aortic arch anomalies. Congenit Heart Dis 2008 3 117-123
11. Didier D, etal. Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography; correlation with echocardiography and surgery. Int J Cardiovasc Imaging 2006 22 457-475
12. Fratz S, etal. More accurate quantification of pulmonary blood flow by magnetic resonance imaging than by lung perfusion scintigraphy in patients with fontan circulation. Circulation 2002 106 1510-1513
13. Godart F, etal. Coarctation of the aorta: comparison of aortic dimensions between conventional MR imaging, 3D MR angiography, and conventional angiography. Eur Radiol 2002 12 2034-2039
14. Greil GF, etal. Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. Pediatr Radiol 2007 37 666-673
15. Gross CM, etal. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes. J Endovasc Ther 2004 11 705-711
16. Grosse-Wortmann L, etal. Borderline hypoplasia of the left ventricle in neonates: insights for decision-making from functional assessment with magnetic resonance imaging. J Thorac Cardiovasc Surg 2008 136 1429-1436
17. Gutberlet M, etal. Arterial Switch Procedure for D-Transposition of the Great Arteries: Quantitative Midterm Evaluation of Hemodynamic Changes with Cine MR Imaging and Phase-Shift Velocity Mapping-Initial Experience. Radiology 2000 214 467-475
18. Helbing WA, de Roos A. Clinical application of cardiac magnetic resonance imaging after repair of tetralogy of Fallot. Pediatr Cardiol 2000 21 70-79
19. Krueger JJ, etal. Magnetic resonance imaging-guided balloon angioplasty of coarctation of the aorta: a pilot study. Circulation 2006 113 1093-1100
20. Ley S, etal. Evaluation of aortic regurgitation in congenital heart disease: value of MR imaging in comparison to echocardiography. Pediatr Radiol 2007 37 426-436
21. Lim DS, etal. Cardiovascular magnetic resonance of pulmonary artery growth and ventricular function after Norwood procedure with Sano modification. J Cardiovasc Magn Reson 2008 10 34
22. Mavrogeni, etal. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol 2004 43 649-652
23. McCrohon JA, etal. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003 108 54-59
24. McKenna WJ, etal. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994 71 215-218
25. Ming Z, etal. Diagnosis of congenital obstructive aortic arch anomalies in Chinese children by contrast-enhanced magnetic resonance angiography. J Cardiovasc Magn Reson 2006 8 747-753
26. Moon JC, etal. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003 41 1561-1567
27. Muthurangu V, etal. Cardiac magnetic resonance imaging after stage I Norwood operation for hypoplastic left heart syndrome. Circulation 2005 112 3256-3263
28. Nagel E, etal. Klinische Indikationen fr die kardiovaskuläre Magnetresonanztomografie (CMR). Clin Res Cardiol Suppl 2007 2 2 77-96
29. Newburger JW, etal. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004 110 2747-2771
30. Pennell DJ, etal. Society for Cardiovascular Magnetic Resonance; Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004 25 1940-1965
31. Peters SA, etal. Muscular magnetic resonance imaging for evaluation of myopathies in children. Klin Padiatr 2008 220 37-46
32. Prasad SK, etal. Role of magnetic resonance angiography in the diagnosis of major aortopulmonary collateral arteries and partial anomalous pulmonary venous drainage. Circulation 2004 109 207-214
33. Raith W, etal. How does the time of diagnosis affect the course of disease in children with Kawasaki syndrome? A retrospective analysis at one center. Klin Padiatr 2009 221 83-88
34. Richardson P, etal. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996 93 841-842
35. Rickers C, etal. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005 112 855-861
36. Roest AA, etal. Aortic coarctation. In: Manning WJ, Pennel DJ, Hrsg. Cardiovascular Magnetic Resonance Churchill Livingstone, Philadelphia 2002 S295-297
37. Schmitt F, etal. 3 Tesla-MRT: Der Erfolg hherer Feldstärken. Der Radiologe 2004 44 31-48
38. Shehata ML, etal. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies. Top Magn Reson Imaging 2008 19 43-57
39. Smit JW, etal. Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab 2001 86 4638-4643
40. Strohm O, etal. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging 2001 13 367-371
41. Suzuki A, etal. Remodeling of coronary artery lesions due to Kawasaki disease: Comparison of arteriographic and immunohistochemical findings. Jpn Heart J 2000 41 245-256 (Pubitemid 30636369)
42. Valsangiacomo Buechel E, etal. Normal right- and left ventricular volumes and myocardial mass in children measured by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2009 11 19
43. von Kodolitsch Y, etal. Diagnosis and management of Marfan syndrome. Future Cardiology 2008 4 85-96
44. Wald RM, etal. Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume? Eur Heart J 2009 30 356-361